| CAT # | Khoom npe | Kev piav qhia |
| PIB 111306 | 7-bromo-2,4,6-trichloro-8-fluoroquinazoline | |
| PAB 113109 | ARS-1323-Alkyne | ARS-1323-alkyne, hloov-II hnab tshos (S-IIP) inhibitor |
| PAB 801183 | VVD-214; RO7589831; VVD-133214 | VVD-214 yog hluavtaws WRN helicase lethal allosteric inhibitor. |
| TIAB SA 801366 | Inlexisertib; DCC-3116 | DCC-3116 yog qhov ncauj qhov ncauj ULK1/2 inhibitor. |
| TIAB SA 601378 | Nonylacridine Txiv kab ntxwv | |
| PIB 112537 | 4H-1,3-Dioxolo [4,5-c] pyrrole-4-carboxylic acid, ... | |
| TIAB SA 801763 | TIAB SA 3138 | MC3138 yog xaiv SIRT5 activator. |
| TIAB SA 801758 | Chk1-IN-6 | Chk1-IN-6 yog lub zog, xaiv, thiab hais lus bioavailable CHK1 tus neeg sib tw inhibitor. |
| PIB 113410 | NDI-101150 | NDI-101150 yog ib qho muaj zog thiab xaiv inhibitor ntawm HPK1 (hematopoietic progenitor cell kinase 1). |
| TIAB SA 601453 | BMS-986408 IB | BMS-986408 yog ib qho kev hais lus zoo dual DGK α / Zeta inhibitor. |
| TIAB SA 601445 | AZD0780;EX-A6975;laroprovstatum; larorovstat | PCSK9-IN-12 yog ib qho heteroaromatic compound. PCSK9-IN-12 muaj kev sib raug zoo rau PCSK9 nrog tus nqi Kd<200 nM. PCSK9-IN-12 tuaj yeem siv rau kev kawm txog cov roj cholesterol metabolism. |
| TIAB SA 601447 | PF07328948 | PF-07328948 yog ib qho kev hais lus zoo BDK (branched chain ketone dehydrogenase kinase) inhibitor. |
| PAB 112881 | (1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hy... | |
| PAB 108261 | LOXO-305; LY 3527727; Pirtobrutinib | Pirtobrutinib (LOXO-305) yog ib qho kev xaiv zoo heev thiab tsis yog covalent tiam tom ntej BTK inhibitor uas tuaj yeem cuam tshuam ntau yam kev hloov pauv BTK C481. |
| PIB 115335 | Luxdegalutamide; TIAB SA-766 | Luxdegalutamide (ARV-766) yog ib qho kev hais lus zoo protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), uas tuaj yeem degrade AR tiv thaiv mutants. |
| TIAB SA 601356 | iHSP110-33 | |
| PAB 800487 | TIAB SA 462 | TNG-462 yog ib qho kev hais lus zoo xaiv PRMT5 inhibitor. |
| TIAB SA 801649 | 1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... | EED ligand 1 yog ntau haiv neeg thiab muaj txiaj ntsig inhibitor uas tsom rau EED subunit ntawm methyltransferase PRC2. |
| TIAB SA 400208 | 6,7-Difluoro-4(3H)-quinazolinone | |
| TIAB SA 801752 | N-(4-quinolinylcarbonyl)Glycine | |
| TIAB SA 400190 | Methyl 5-bromo-2-methyl-3- (trifluoromethyl) benz... | |
| PAB 800126 | IDE 397 (GSK-4362676) | |
| PAB 801185 | NWS-628 | NST-628 yog MAPK txoj hauv kev molecular gel nrog ntshav-hlwb barrier permeability, uas tuaj yeem cuam tshuam RAF phosphorylation thiab MEK ua kom. |
| PIB 115153 | NX-2127 | NX-2127 yog qhov ncauj zoo BTK inhibitor. |
